Literature DB >> 20133334

A consensus-based guideline defining the clinical target volume for pelvic lymph nodes in external beam radiotherapy for uterine cervical cancer.

Takafumi Toita, Tatsuya Ohno, Yuko Kaneyasu, Takashi Uno, Ryouichi Yoshimura, Takeshi Kodaira, Kazuhisa Furutani, Goro Kasuya, Satoshi Ishikura, Toshiharu Kamura, Masahiro Hiraoka.   

Abstract

OBJECTIVE: To develop a consensus-based guideline as well as an atlas defining pelvic nodal clinical target volumes in external beam radiotherapy for uterine cervical cancer.
METHODS: A working subgroup to establish the consensus-based guideline on clinical target volumes for uterine cervical cancer was formulated by the Radiation Therapy Study Group of the Japan Clinical Oncology Group in July 2008. The working subgroup consisted of seven radiation oncologists. The process resulting in the consensus included a comparison of contouring on CT images among the members, reviewing of published textbooks and the relevant literature and a distribution analysis of metastatic nodes on computed tomography/magnetic resonance imaging of actual patients.
RESULTS: The working subgroup defined the pelvic nodal clinical target volumes for cervical cancer and developed an associated atlas. As a basic criterion, the lymph node clinical target volume was defined as the area encompassed by a 7 mm margin around the applicable pelvic vessels. Modifications were made in each nodal area to cover adjacent adipose tissues at risk of microscopic nodal metastases. Although the bones and muscles were excluded, the bowel was not routinely excluded in the definition. Each of the following pelvic node regions was defined: common iliac, external iliac, internal iliac, obturator and presacral. Anatomical structures bordering each lymph node region were defined for six directions; anterior, posterior, lateral, medial, cranial and caudal. Drafts of the definition and the atlas were reviewed by members of the JCOG Gynecologic Cancer Study Group (GCSG).
CONCLUSIONS: We developed a consensus-based guideline defining the pelvic node clinical target volumes that included an atlas. The guideline will be continuously updated to reflect the ongoing changes in the field.

Entities:  

Mesh:

Year:  2010        PMID: 20133334     DOI: 10.1093/jjco/hyp191

Source DB:  PubMed          Journal:  Jpn J Clin Oncol        ISSN: 0368-2811            Impact factor:   3.019


  36 in total

1.  Incidental Dose to Pelvic Nodal Regions in Prostate-Only Radiotherapy.

Authors:  Vedang Murthy; Shirley Lewis; Mayur Sawant; Siji N Paul; Umesh Mahantshetty; Shyam Kishore Shrivastava
Journal:  Technol Cancer Res Treat       Date:  2016-08-19

2.  Strategies for reducing ovarian dose in volumetric modulated arc therapy (VMAT) for postoperative uterine cervical cancer.

Authors:  Ueda Yoshihiro; Ohira Shingo; Isono Masaru; Miyazaki Masayoshi; Konishi Koji; Kamiura Shoji; Sumida Iori; Ogawa Kazuhiko; Teshima Teruki
Journal:  Br J Radiol       Date:  2017-11-03       Impact factor: 3.039

3.  Feasibility of extended-field irradiation and intracavitary brachytherapy combined with weekly cisplatin chemosensitization for IB2-IIIB cervical cancer with positive paraaortic or high common iliac lymph nodes: a retrospective review.

Authors:  Shiho Kuji; Yasuyuki Hirashima; Satomi Komeda; Aki Tanaka; Masakazu Abe; Nobutaka Takahashi; Munetaka Takekuma; Hirofumi Asakura; Hideyuki Harada; Tetsuo Nishimura
Journal:  Int J Clin Oncol       Date:  2013-04-02       Impact factor: 3.402

4.  Radiotherapy quality assurance of the Japanese Gynecologic Oncology Group study (JGOG1066): a cooperative phase II study of concurrent chemoradiotherapy for uterine cervical cancer.

Authors:  Takafumi Toita; Shingo Kato; Satoshi Ishikura; Kayoko Tsujino; Takeshi Kodaira; Takashi Uno; Kazuo Hatano; Hideyuki Sakurai; Yuzuru Niibe; Tomoko Kazumoto; Tetsuo Nishimura; Ryo Kitagawa; Miki Fukutani; Masahiko Oguchi; Kenji Umayahara; Yasuyuki Hirashima; Yoichi Aoki; Ken Takizawa
Journal:  Int J Clin Oncol       Date:  2011-02-18       Impact factor: 3.402

5.  Quantitative assessment of target delineation variability for thymic cancers: Agreement evaluation of a prospective segmentation challenge.

Authors:  Emma Holliday; Clifton D Fuller; Jayashree Kalpathy-Cramer; Daniel Gomez; Andreas Rimner; Ying Li; Suresh Senan; Lynn D Wilson; Jehee Choi; Ritsuko Komaki; Charles R Thomas
Journal:  J Radiat Oncol       Date:  2015-11-03

6.  Treatment Outcome of the Combination Therapy of High-dose rate Intracavitary Brachytherapy and Intensity-modulated Radiation Therapy With Central-shielding for Cervical Cancer.

Authors:  Yuki Mukai; Yumiko Minagawa; Hiromi Inoue; Akiko Sato; Kengo Matsui; Takanori Fukuda; Kazuya Onuma; Hideyuki Hongo; Ryosuke Shirata; Hironori Nagata; Harumitu Hashimoto; Tomio Inoue; Masaharu Hata; Motoko Omura
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

7.  Plan-Optimization Method for Central-shielding Pelvic Volumetric-modulated Arc Therapy for Cervical Cancer.

Authors:  Ryuta Hirai; Tomoaki Tamaki; Mitsunobu Igari; Y U Kumazaki; Shin-Ei Noda; Shingo Kato
Journal:  In Vivo       Date:  2020 Nov-Dec       Impact factor: 2.155

8.  Dosimetric impact of rotational setup errors in volumetric modulated arc therapy for postoperative cervical cancer.

Authors:  Katsutomo Tsujii; Yoshihiro Ueda; Masaru Isono; Masayoshi Miyazaki; Teruki Teshima; Masahiko Koizumi
Journal:  J Radiat Res       Date:  2021-07-10       Impact factor: 2.724

9.  Distribution patterns of metastatic pelvic lymph nodes assessed by CT/MRI in patients with uterine cervical cancer.

Authors:  Goro Kasuya; Takafumi Toita; Kazuhisa Furutani; Takeshi Kodaira; Tatsuya Ohno; Yuko Kaneyasu; Ryouichi Yoshimura; Takashi Uno; Akira Yogi; Satoshi Ishikura; Masahiro Hiraoka
Journal:  Radiat Oncol       Date:  2013-06-08       Impact factor: 3.481

10.  Image-guided brachytherapy (IGBT) combined with whole pelvic intensity-modulated radiotherapy (WP-IMRT) for locally advanced cervical cancer: a prospective study from Chiang Mai University Hospital, Thailand.

Authors:  Ekkasit Tharavichitkul; Somsak Wanwilairat; Somvilai Chakrabandhu; Pitchayaponne Klunklin; Wimrak Onchan; Damrongsak Tippanya; Wannapa Nopnop; Razvan Galalae; Imjai Chitapanarux
Journal:  J Contemp Brachytherapy       Date:  2013-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.